The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
High-risk constitutional MLH1 methylation as a cause of early-onset colorectal and endometrial cancers displaying mismatch repair deficiency and MLH1 methylation.
 
Megan Philippa Hitchins
Patents, Royalties, Other Intellectual Property - Methylated DNA markers and assays thereof for use in detecting colorectal cancer. Hitchins M, Haile R, Snyder M, Lee H. Cedars-Sinai MC Tech NP: 65472-891PR0 Provisional Patent Application 3/10/2022.
Travel, Accommodations, Expenses - Epigenomics
 
Rocio Alvarez
No Relationships to Disclose
 
Francesca Paola Aguirre
No Relationships to Disclose
 
Lisa Zhou
No Relationships to Disclose
 
Marcio A. Diniz
No Relationships to Disclose
 
Xiaopu Yuan
No Relationships to Disclose
 
Estela Damaso
No Relationships to Disclose
 
Rachel Hodan
No Relationships to Disclose
 
Shawnia R Ryan
No Relationships to Disclose
 
Timothy Lewis Cannon
Honoraria - AstraZeneca; Bayer; Deciphera
Consulting or Advisory Role - Intermountain Healthcare
Other Relationship - Navican/ Intermountain Healthcare
 
Rakesh Biswas
No Relationships to Disclose
 
Tiffani DeMarco
No Relationships to Disclose
 
Devika Sathe
No Relationships to Disclose
 
Erin E. Salo-Mullen
No Relationships to Disclose
 
Zsofia Kinga Stadler
Consulting or Advisory Role - Adverum (I); Genentech/Roche (I); Gyroscope (I); Neurogene (I); Optos (I); Outlook Therapeutics (I); Regeneron (I); Regenxbio (I)
 
Rachel Pearlman
No Relationships to Disclose
 
Heather Hampel
Stock and Other Ownership Interests - Genome Medical; GI OnDemand
Consulting or Advisory Role - 23andMe; Genome Medical; GI OnDemand; InVitae; Natera; Promega